Blood-brain barrier disruption using reversible or irreversible electroporation
The present invention provides methods, devices, and systems for in vivo treatment of cell proliferative disorders. Included is a method of treating tissue with electrical energy, the method comprising: delivering electrical energy to tissue using one or more electroporation devices comprising one or more electrodes; and cooling the tissue, surrounding tissue, one or more of the electrodes, or one or more of the electroporation devices to minimize heating. In embodiments, the invention can be used to treat solid tumors, such as brain tumors, and in some embodiments, exemplary methods rely on non-thermal irreversible electroporation (IRE) to cause cell death in treated tumors.
1. A method comprising:
inserting a probe into a target tissue, wherein the probe comprises:
a first electrode configured to be operatively coupled to a power supply; and
a non-conductive region; and
activating the power supply to apply electrical pulses via the first electrode in an amount sufficient to induce cell death by ablation of cells in the target tissue in vivo, thereby creating a tissue scaffold;
wherein the electrical pulses alternate in polarity; and
wherein the electrical pulses are applied in a manner to maintain a temperature of the target tissue of 100° C. or less for a period of time that avoids thermal damage to cells of the target tissue.
2. The method of claim 1 , wherein the temperature is maintained at 60° C. or less.
3. The method of claim 1 , wherein the temperature is maintained at 50° C. or less.
4. The method of claim 1 , further comprising:
infusing a material into the target tissue.
5. The method of claim 4 , wherein the material is a chemotherapeutic agent.
6. The method of claim 4 , wherein the material comprises a single or multi-walled carbon nanotubes (CNTs); a conductive gel; an antibiotic; an anti-inflammatory; an anesthetic; a muscle relaxer; or a nerve relaxer.
7. The method of claim 1 , further comprising:
monitoring the temperature and/or impedance of the target tissue.
8. The method of claim 1 , wherein the adjusting of the electrical pulses includes adjusting an applied voltage, a duration of the applied voltage, a length of the electrical pulses, and/or a number of electrical pulses.
9. The method of claim 8 , wherein a user adjusts the electrical pulses.
10. The method of claim 1 , wherein the plurality of pulses have:
a frequency of 0-100 MHz, and
a voltage of 0 V to 5000 V.
11. The method of claim 1 , further comprising an outer, non-conductive sheath moveable along a length of the probe to expose or cover the probe.
12. The method of claim 1 , wherein the electrical pulses are applied between the first electrode and a second electrode.
13. A method comprising:
inserting a probe into a target tissue, wherein the probe comprises:
a first electrode configured to be operatively coupled to a power supply; and
a non-conductive region; and
activating the power supply to apply electrical pulses via the first electrode in an amount sufficient to induce cell death by ablation of cells in the target tissue in vivo, thereby creating a tissue scaffold;
wherein the electrical pulses alternate in polarity; and
wherein the electrical pulses are applied in a manner to maintain a temperature of the target tissue of 100° C. or less for a period of time that avoids thermal damage to cells of the target tissue, using a selected applied voltage, a duration of the applied voltage, a length of the electrical pulses, and/or a number of the electrical pulses.
14. The method of claim 13 , wherein the temperature is maintained at 60° C. or less.
15. The method of claim 13 , wherein the temperature is maintained at 50° C. or less.
16. The method of claim 13 , further comprising:
infusing a material into the target tissue.
17. The method of claim 16 , wherein the material is a chemotherapeutic agent.
18. The method of claim 16 , wherein the material is a single or multi-walled carbon nanotubes (CNTs); a conductive gel; an antibiotic; an anti-inflammatory; an anesthetic; a muscle relaxer; or a nerve relaxer.
19. The method of claim 13 , wherein the monitoring includes monitoring the temperature and/or the impedance of the target tissue.
20. The method of claim 13 , further comprising monitoring for a change in electrical impedance of the target zone in real-time.
21. The method of claim 13 , wherein the plurality of pulses have:
a frequency of 0-100 MHz, and
a voltage of 0 V to 5000 V.
22. The method of claim 13 , further comprising an outer, non-conductive sheath moveable along a length of the probe to expose or cover the probe.
23. The method of claim 13 , wherein the electrical pulses are applied between the first electrode and a second electrode.